The Use of Neuromuscular Blockade Monitor as a Strategy for Neuromuscular Blockade Agents Saving in ICU COVID-19 Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04459533

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:39.827774+00:00

Published At

2020-07-07T00:00:00+00:00

Record Updated At

2020-07-07

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Neuromuscular Blockade", "Human Characteristics", "Complication of Medical Care", "Intensive Care Unit Acquired Weakness"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2020-07-07"

protocolSection.identificationModule.nctId

"NCT04459533"

protocolSection.identificationModule.officialTitle

"The Use of Neuromuscular Blockade Monitor as a Strategy for Neuromuscular Blockade Agents Saving in ICU COVID-19 Patients"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Neuromuscular Blockade (protocolSection.conditionsModule.conditions)
• Human Characteristics (protocolSection.conditionsModule.conditions)
• Complication of Medical Care (protocolSection.conditionsModule.conditions)
• Intensive Care Unit Acquired Weakness (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.